{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-050002","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.270259+00:00","generated_at":"2026-05-29T00:11:31.216273+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ADMA Biologics repays $30M of senior secured term loan, total debt reduced to $75M","bullets":["Repaid $30M of original $62.5M term loan with Ares Capital using cash on hand.","Total gross debt now $75M: $42.5M revolver plus $32.5M term loan outstanding.","This is second paydown in four months; total gross debt reduced by 29%.","Lowered interest expense expected to enhance near-term earnings growth potential.","CEO cites confidence in sustained earnings growth and ongoing cash generation."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-050002","json":"https://secwatch.observer/filing/0001140361-24-050002.json","markdown":"https://secwatch.observer/filing/0001140361-24-050002.md","text":"https://secwatch.observer/filing/0001140361-24-050002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/0001140361-24-050002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036124050002/ef20040424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:11:31.216273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}